-
A Systematic Literature Review and Meta-Analysis Comparing Benign Robotic-Assisted Inguinal Hernia Repair Using the da Vinci Surgical Systems to Laparoscopic or Open Approach
Mar 10, 2025, 14:00 PM -
Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Early Breast Cancer Patients
Mar 10, 2025, 14:00 PM -
Beyond Overall Survival: Advancing the Understanding and Use of Surrogate Endpoints in Oncology
Mar 10, 2025, 14:00 PM -
Methods for Handling Non-Proportional Hazards in Economic Modeling
Mar 10, 2025, 14:00 PM -
Description and Healthcare Resource Utilization of Patients With Moderate or Severe Lupus Using US Insurance Claims
Mar 10, 2025, 14:00 PM -
Indirect Treatment Comparison (ITC) of Mirdametinib and Selumetinib for the Treatment of Children with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (NF1-PN)
Mar 10, 2025, 14:00 PM -
Direct Costs of Pneumococcal Disease in the United States - A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Methodological Variations in Systematic Reviews of Health Economic Models
Mar 10, 2025, 14:00 PM -
Exploring the Equity of Out-of-Pocket Healthcare Expenses and Catastrophic Healthcare Expenditures in Taiwanese Households
Mar 10, 2025, 14:00 PM -
Analysis of the Burden of Illness, Treatment, and Health Disparities in Amyotrophic Lateral Sclerosis
Mar 10, 2025, 14:00 PM -
Quality-Adjusted Life Year (QALY) Results From a Cost-Effectiveness Model for Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Relapsed/Refractory Multiple Myeloma (RRMM)
Mar 10, 2025, 14:00 PM -
Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)
Mar 10, 2025, 14:00 PM -
Racial/Ethnic Disparities in Veterans' Healthcare Experiences Across VA and Non-VA Settings: An Analysis of the Medical Expenditure Panel Survey (2018-2019)
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization and Costs of Schizophrenia Among Medicaid Beneficiaries
Mar 10, 2025, 14:00 PM -
Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Mar 10, 2025, 14:00 PM -
Investigating the Potential of Extracting Answers to Health-Related Quality of Life Questionnaires From Patient Community Data
Mar 10, 2025, 14:00 PM -
The Impact of Mucopolysaccharidosis Type III (MPS III) on Family and Finances: A Caregiver Perspective
Mar 10, 2025, 14:00 PM -
Impact of Procedure Wait Times on One-Year Health Outcomes in Patients With Degenerative Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling.
Mar 10, 2025, 14:00 PM -
Health-Related Quality of Life and Productivity Losses Across Stages of Breast and Colorectal Cancer
Mar 10, 2025, 14:00 PM
